Metric Deep Dive: Understanding Cardinal Health, Inc. (CAH) Through its Ratios

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

After finishing at $98.04 in the prior trading day, Cardinal Health, Inc. (NYSE: CAH) closed at $97.43, down -0.62%. In other words, the price has decreased by -$0.62 from its previous closing price. On the day, 1.33 million shares were traded. CAH stock price reached its highest trading level at $98.65 during the session, while it also had its lowest trading level at $96.95.

Ratios:

Our goal is to gain a better understanding of CAH by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.38 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.82. For the most recent quarter (mrq), Quick Ratio is recorded 0.51 and its Current Ratio is at 0.98.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on February 26, 2024, initiated with a Outperform rating and assigned the stock a target price of $125.

On January 03, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $117.Barclays initiated its Overweight rating on January 03, 2024, with a $117 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 27 ’23 when WEITZMAN DEBORAH sold 36,642 shares for $106.31 per share. The transaction valued at 3,895,411 led to the insider holds 35,202 shares of the business.

WEITZMAN DEBORAH sold 6,712 shares of CAH for $602,805 on Aug 28 ’23. The CEO, Pharmaceutical Segment now owns 44,202 shares after completing the transaction at $89.81 per share. On Aug 18 ’23, another insider, Scherer Mary C., who serves as the Chief Accounting Officer of the company, sold 20,695 shares for $86.27 each. As a result, the insider received 1,785,358 and left with 10,649 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAH now has a Market Capitalization of 23879313408 and an Enterprise Value of 25869727744. As of this moment, Cardinal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 43.19, and their Forward P/E ratio for the next fiscal year is 12.87. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.91. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.11. Its current Enterprise Value per Revenue stands at 0.117 whereas that against EBITDA is 9.296.

Stock Price History:

Over the past 52 weeks, CAH has reached a high of $116.04, while it has fallen to a 52-week low of $80.90. The 50-Day Moving Average of the stock is -9.41%, while the 200-Day Moving Average is calculated to be -3.00%.

Shares Statistics:

The stock has traded on average 2.25M shares per day over the past 3-months and 2274740 shares per day over the last 10 days, according to various share statistics. A total of 251.00M shares are outstanding, with a floating share count of 242.12M. Insiders hold about 0.60% of the company’s shares, while institutions hold 91.15% stake in the company. Shares short for CAH as of 1714435200 were 8498219 with a Short Ratio of 3.78, compared to 1711584000 on 9040957. Therefore, it implies a Short% of Shares Outstanding of 8498219 and a Short% of Float of 4.66.

Dividends & Splits

In the trailing 12 months, CAH’s forward annual dividend rate was 2.002, compared to 2.00 this year. Against a Trailing Annual Dividend Yield of 0.020420237The stock’s 5-year Average Dividend Yield is 3.24.

Most Popular

[the_ad id="945"]